Organigram Holdings Inc. (OGI)
NASDAQ: OGI · Real-Time Price · USD
1.800
+0.070 (4.05%)
Nov 4, 2024, 4:00 PM EST - Market closed

Company Description

Organigram Holdings Inc., through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada.

It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O’ Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co., Edison JOLTS, Tremblant, and Laurentian brands.

The company also engages in the wholesale shipping of cannabis plant cuttings, dried flowers, blends, pre-rolls, and cannabis derivative-based products to retailers and wholesalers for adult-use recreational cannabis.

It sells its products through online, as well as consumer channels. The company was incorporated in 2010 and is headquartered in Toronto, Canada.

Organigram Holdings Inc.
Organigram Holdings logo
Country Canada
Founded 2013
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 984
CEO Beena Goldenberg

Contact Details

Address:
145 King Street West, Suite #1400
Toronto, ON M5H 1J8
Canada
Website organigram.ca

Stock Details

Ticker Symbol OGI
Exchange NASDAQ
Fiscal Year October - September
Reporting Currency CAD
CIK Code 0001620737
CUSIP Number 68620P101
ISIN Number CA68620P7056
SIC Code 2834

Key Executives

Name Position
Beena G. Goldenberg Chief Executive Officer and Director
Helen Martin Chief Legal Officer and Corporate Secretary
Timothy Emberg Chief Commercial Officer
Paolo De Luca C.A., C.F.A Chief Strategy Officer
Greg Guyatt C.A., CPA Chief Financial Officer
Nathalie Batten Senior Vice President of Operations
Geoff Riggs Chief Information Officer
Max Schwartz Director of Investor Relations
Megan Amber McCrae Senior Vice President of Marketing and Communications
Katrina May McFadden Chief People Officer

Latest SEC Filings

Date Type Title
Sep 3, 2024 SC 13D/A [Amend] General statement of acquisition of beneficial ownership
Sep 3, 2024 6-K Report of foreign issuer
Aug 13, 2024 6-K Report of foreign issuer
Aug 7, 2024 6-K Report of foreign issuer
Aug 6, 2024 6-K Report of foreign issuer
Jul 29, 2024 6-K Report of foreign issuer
Jul 24, 2024 6-K Report of foreign issuer
Jul 12, 2024 6-K Report of foreign issuer
Jun 25, 2024 6-K Report of foreign issuer
May 28, 2024 6-K Report of foreign issuer